Spots Global Cancer Trial Database for recurrent retinoblastoma
Every month we try and update this database with for recurrent retinoblastoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features | NCT01048892 | Adrenocortical ... Gastrointestina... Kidney Cancer Neuroblastoma Retinoblastoma Sarcoma | Seneca Valley v... cyclophosphamid... laboratory biom... pharmacological... | 3 Years - 21 Years | Children's Oncology Group | |
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma | NCT00006102 | Brain and Centr... Lymphoma Neuroblastoma Retinoblastoma Sarcoma Unspecified Chi... | becatecarin | - 21 Years | National Cancer Institute (NCI) | |
High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors | NCT00003173 | Brain and Centr... Childhood Germ ... Extragonadal Ge... Ovarian Cancer Retinoblastoma Testicular Germ... Unspecified Adu... Unspecified Chi... | filgrastim thiotepa autologous bone... peripheral bloo... | - | Memorial Sloan Kettering Cancer Center | |
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors | NCT00003926 | Brain and Centr... Childhood Germ ... Chordoma Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Retinoblastoma Sarcoma | amifostine trih... busulfan filgrastim melphalan thiotepa peripheral bloo... | 1 Year - 45 Years | Masonic Cancer Center, University of Minnesota | |
Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma | NCT00004006 | Retinoblastoma | filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide topotecan hydro... autologous bone... radiation thera... | - 15 Years | St. Jude Children's Research Hospital | |
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors | NCT00003926 | Brain and Centr... Childhood Germ ... Chordoma Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Retinoblastoma Sarcoma | amifostine trih... busulfan filgrastim melphalan thiotepa peripheral bloo... | 1 Year - 45 Years | Masonic Cancer Center, University of Minnesota | |
Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers | NCT00690469 | Extraocular Ret... Intraocular Ret... Recurrent Retin... | Laboratory Biom... Questionnaire A... | - | Children's Oncology Group | |
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features | NCT01048892 | Adrenocortical ... Gastrointestina... Kidney Cancer Neuroblastoma Retinoblastoma Sarcoma | Seneca Valley v... cyclophosphamid... laboratory biom... pharmacological... | 3 Years - 21 Years | Children's Oncology Group | |
Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma | NCT00004006 | Retinoblastoma | filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide topotecan hydro... autologous bone... radiation thera... | - 15 Years | St. Jude Children's Research Hospital | |
Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers | NCT00690469 | Extraocular Ret... Intraocular Ret... Recurrent Retin... | Laboratory Biom... Questionnaire A... | - | Children's Oncology Group |